NattoNSP-2™ (Nattokinase) References

  1. Centers for Disease Control and Prevention; “Heart Disease Facts” Oct 26, 2012 http://www.cdc.gov/heartdisease/facts.htm
  2. Shurleff, W.; Aoyagi, A. 2012 “History of Natto and Its Relatives (1405-2012).” Lafayette, California: Soyinfo Center. 657 pp.
  3. Hsia, CH; et al. 2009 “Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects.” Nutrition Research. 29 (2009) 190-196.
  4. Sumi, H. et al. “Heated natto and nattokinase found to have significant activity on human cells to promote release of t-PA” Kurashiki University of Science and the Arts, Dept. of Life Sciences
  5. Wang, Q. D. John, P. , Sjoquist, P. O. and Lars, R. (2002) Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovascular Research. 55, 25-37
  6. Turko, I.V. and Murad, F. (2002) Protein nitration in cardiovascular diseases. Pharmacological Review. 54 619-634
  7. Ko, J., Yan J., Lei Z, and Qi Y. (2005) Subtilisin QK, a Fibronolytic Enzyme, Inhibits the Exogenous Nitrite and Hydrogen Peroxide Induced Protein Nitration, inVitro and inVivo. Journal of Biochemistry and Molecular Biology. 38 577-583
  8. Yan, F. Yan, J., Sun W, Yao L, Wang J, Qi Yipeng, Xu Hua, (2009) Thrombolytic Effect of Subtilisin QK on carrageenan induced thrombosis model in mice. Journal of Thromb Thrombolysis. 10.1007/s11239-009-0333-3

Additional NattoNSP-2™  Info:

Maximize Blood Circulation: The Benefits of Natto NSP-2™